SCHEMBL7744769

SCHEMBL7744769

CC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1C1=CC(=S)CC=C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.53
FLT1 P17948 1/20 0.53
FLT4 P35916 1/20 0.53
KDM4E B2RXH2 3/20 0.38
HDAC1 Q13547 3/20 0.38
APOBEC3A P31941 1/20 0.38
GFER P55789 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
NR4A2 P43354 1/20 0.34
EGFR P00533 1/20 0.34
PIK3CG P48736 1/20 0.34
ALOX15 P16050 1/20 0.34
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
POLB P06746 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7982717 0.93 KDR (0.44) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7982846 0.91 KDR (0.49) KDRFLT1FLT4ALOX15ADORA2A
SCHEMBL7980279 0.90 KDR (0.47) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7746568 0.90 KDR (0.41) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7981120 0.89 KDR (0.47) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7739072 0.88 KDR (0.43) KDRFLT1FLT4KDM4ESMN1; SMN2
SCHEMBL7744069 0.87 KDR (0.40) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7986013 0.87 KDR (0.39) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7980106 0.85 KDR (0.42) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7979682 0.85 KDR (0.46) KDRFLT1FLT4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed